ISFM猫高血压诊断与管理共识指南
该指南由国际猫医学会(ISFM)基于现有文献综述制定,针对猫高血压(常与慢性肾病、甲状腺功能亢进等继发因素相关,也可见明显原发性高血压)的临床挑战提供实践建议。指南强调血压测量技术需可重复且准确、识别并监测高危猫、建立治疗干预标准和治疗目标。基于现有数据,苯磺酸氨氯地平是猫高血压的治疗选择,对多数猫有效,但所需剂量因个体而异,部分猫需长期辅助治疗,偶需额外治疗以紧急处理高血压危象。指南指出许多领域仍需更多数据,未来将用于确认或修改部分推荐。
要点
- 猫高血压常见于老年猫,常与慢性肾病、甲状腺功能亢进等疾病相关(继发性高血压),也可见明显原发性高血压。
- 常规血压监测在临床实践中开展不频繁,可能导致猫高血压诊断不足,需确保以可重复技术尽可能准确测量血压。
- 需识别并监测有高血压风险的猫,建立适当的治疗干预标准和治疗目标。
- 基于现有数据,苯磺酸氨氯地平是猫高血压的治疗选择,对多数猫有效,但所需剂量因个体而异。
- 部分猫需长期辅助治疗,偶需额外治疗以紧急处理高血压危象;指南许多领域仍需更多数据。
适用人群与场景
- 老年猫,尤其与慢性肾病、甲状腺功能亢进等其他疾病相关的继发性高血压猫,也可见明显原发性高血压猫。
处置流程与药物剂量
- 基于当前数据,苯磺酸氨氯地平是管理猫高血压的治疗选择,对多数猫有效,但所需剂量因个体而异。
- 部分猫需要长期辅助治疗,偶尔需要额外治疗以紧急处理高血压危象。
红旗征与不能漏的情况
- 高血压的临床后果可能严重,与靶器官损伤(眼、心脏和血管、脑和肾脏)相关。
研究设计与关键结果
- 指南由国际猫医学会(ISFM)基于对现有文献的全面综述制定,旨在为兽医提供应对猫高血压挑战的实践建议。
- 指南指出许多领域需要更多数据,未来将用于确认或修改部分推荐。
证据类型、等级与局限
- 证据类型:共识指南,基于对现有文献的全面综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 临床实践中血压监测开展不频繁,可能导致猫高血压诊断不足,需确保以可重复技术尽可能准确测量血压。
- 需识别并监测有高血压风险的猫,建立适当的治疗干预标准和治疗目标。
- 苯磺酸氨氯地平是猫高血压的治疗选择,对多数猫有效,但剂量需个体化,部分猫需长期辅助治疗。
指南或共识出处
- ISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in Cats(国际猫医学会猫高血压诊断与管理共识指南),发布机构:国际猫医学会(ISFM)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Practical relevance: Feline hypertension is a common disease in older cats that is frequently diagnosed in association with other diseases such as chronic kidney disease and hyperthyroidism (so-called secondary hypertension), although some cases of apparent primary hypertension are also reported. The clinical consequences of hypertension can be severe, related to 'target organ damage' (eye, heart and vasculature, brain and kidneys), and early diagnosis followed by appropriate therapeutic management should help reduce the morbidity associated with this condition. Clinical challenges: Despite being a common disease, routine blood pressure (BP) monitoring is generally performed infrequently, probably leading to underdiagnosis of feline hypertension in clinical practice. There is a need to: (i) ensure BP is measured as accurately as possible with a reproducible technique; (ii) identify and monitor patients at risk of developing hypertension; (iii) establish appropriate criteria for therapeutic intervention; and (iv) establish appropriate therapeutic targets. Based on current data, amlodipine besylate is the treatment of choice to manage feline hypertension and is effective in the majority of cats, but the dose needed to successfully manage hypertension varies between individuals. Some cats require long-term adjuvant therapy and, occasionally, additional therapy is necessary for emergency management of hypertensive crises. Evidence base: These Guidelines from the International Society of Feline Medicine (ISFM) are based on a comprehensive review of the currently available literature, and are aimed at providing practical recommendations to address the challenges of feline hypertension for veterinarians. There are many areas where more data is required which, in the future, will serve to confirm or modify some of the recommendations in these Guidelines.
参考来源
- Taylor SS, Sparkes AH, Briscoe K, et al. ISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in Cats. J Feline Med Surg. 2017. PMID: 28245741. doi:10.1177/1098612X17693500
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。